Allostery in a disordered protein: oxidative modifications to α-synuclein act distally to regulate membrane binding.
暂无分享,去创建一个
Adam J. Trexler | E. Rhoades | E. Sevcsik | Elizabeth Rhoades | Adam J Trexler | Eva Sevcsik | Joanna M Dunn | J. M. Dunn | Eva Sevcsik
[1] W. Webb,et al. Quantification of α-Synuclein Binding to Lipid Vesicles Using Fluorescence Correlation Spectroscopy , 2006 .
[2] D. Lynch,et al. Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation. , 2004, The Journal of biological chemistry.
[3] E. Rhoades,et al. Effects of curvature and composition on α-synuclein binding to lipid vesicles. , 2010, Biophysical journal.
[4] Xiaohui Xu,et al. Nitrated α-Synuclein Induces the Loss of Dopaminergic Neurons in the Substantia Nigra of Rats , 2010, PloS one.
[5] V. Hilser,et al. Intrinsic disorder as a mechanism to optimize allosteric coupling in proteins , 2007, Proceedings of the National Academy of Sciences.
[6] J. Trojanowski,et al. Synucleins Are Developmentally Expressed, and α-Synuclein Regulates the Size of the Presynaptic Vesicular Pool in Primary Hippocampal Neurons , 2000, The Journal of Neuroscience.
[7] Ad Bax,et al. Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy. , 2009, Journal of molecular biology.
[8] S. Lindquist,et al. α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models , 2006, Science.
[9] D. Eliezer,et al. Charge neutralization and collapse of the C‐terminal tail of alpha‐synuclein at low pH , 2009, Protein science : a publication of the Protein Society.
[10] Martina Huber,et al. Spin‐Label EPR on α‐Synuclein Reveals Differences in the Membrane Binding Affinity of the Two Antiparallel Helices , 2008, Chembiochem : a European journal of chemical biology.
[11] H. Vorum,et al. Ca2+ Binding to α-Synuclein Regulates Ligand Binding and Oligomerization* , 2001, The Journal of Biological Chemistry.
[12] Adam J. Trexler,et al. Alpha-synuclein binds large unilamellar vesicles as an extended helix. , 2009, Biochemistry.
[13] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[14] E. Bergantino,et al. The reaction of alpha-synuclein with tyrosinase: possible implications for Parkinson disease. , 2008, The Journal of biological chemistry.
[15] Zhou Yu,et al. The induction of folding cooperativity by ligand binding drives the allosteric response of tetracycline repressor , 2009, Proceedings of the National Academy of Sciences.
[16] Adam J. Trexler,et al. Single molecule characterization of α-synuclein in aggregation-prone states. , 2010, Biophysical journal.
[17] Ralf Langen,et al. Structure of membrane-bound α-synuclein studied by site-directed spin labeling , 2004 .
[18] L. Forno,et al. Pathologic Modifications of &agr;-Synuclein in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Treated Squirrel Monkeys , 2008, Journal of neuropathology and experimental neurology.
[19] J. Trojanowski,et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. , 2000, Science.
[20] Robert Edwards,et al. Lipid Rafts Mediate the Synaptic Localization of α-Synuclein , 2004, The Journal of Neuroscience.
[21] Olaf Riess,et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.
[22] E. Masliah,et al. Phosphorylation at S87 Is Enhanced in Synucleinopathies, Inhibits α-Synuclein Oligomerization, and Influences Synuclein-Membrane Interactions , 2010, The Journal of Neuroscience.
[23] D E Wemmer,et al. Two-state allosteric behavior in a single-domain signaling protein. , 2001, Science.
[24] A. Jonas,et al. Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes* , 1998, The Journal of Biological Chemistry.
[25] M. Akke,et al. Structural dynamics in the C-terminal domain of calmodulin at low calcium levels. , 1999, Journal of molecular biology.
[26] P. Lansbury,et al. Phosphorylation at Ser-129 but Not the Phosphomimics S129E/D Inhibits the Fibrillation of α-Synuclein* , 2008, Journal of Biological Chemistry.
[27] Martin Blackledge,et al. Amino acid bulkiness defines the local conformations and dynamics of natively unfolded alpha-synuclein and tau. , 2007, Journal of the American Chemical Society.
[28] D. Eliezer,et al. Residual Structure and Dynamics in Parkinson's Disease-associated Mutants of α-Synuclein* , 2001, The Journal of Biological Chemistry.
[29] P. Højrup,et al. α-Synuclein Binds to Tau and Stimulates the Protein Kinase A-catalyzed Tau Phosphorylation of Serine Residues 262 and 356* , 1999, The Journal of Biological Chemistry.
[30] M. Goedert,et al. Binding of α-Synuclein to Brain Vesicles Is Abolished by Familial Parkinson’s Disease Mutation* , 1998, The Journal of Biological Chemistry.
[31] D. Eliezer,et al. A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins. , 2003, Journal of molecular biology.
[32] S. Lindquist,et al. α-Synuclein: membrane interactions and toxicity in Parkinson's disease. , 2010, Annual review of cell and developmental biology.
[33] J. Benovic,et al. Synucleins Are a Novel Class of Substrates for G Protein-coupled Receptor Kinases* , 2000, The Journal of Biological Chemistry.
[34] Elisha Haas,et al. Segmental conformational disorder and dynamics in the intrinsically disordered protein α-synuclein and its chain length dependence. , 2011, Journal of molecular biology.
[35] Jonathan A. Jones,et al. Characterisation of protein unfolding by NMR diffusion measurements , 1997 .
[36] J. Hoenicka,et al. The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.
[37] R. Perrin,et al. Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis. , 2000, The Journal of biological chemistry.
[38] P. Karplus,et al. Crystal Structure of the Antioxidant Enzyme Glutathione Reductase Inactivated by Peroxynitrite* , 2002, The Journal of Biological Chemistry.
[39] H. Lashuel,et al. E46K Parkinson's-linked mutation enhances C-terminal-to-N-terminal contacts in alpha-synuclein. , 2009, Journal of molecular biology.
[40] J. Kenney,et al. Microtubule-associated Protein 1B Is a Component of Cortical Lewy Bodies and Binds α-Synuclein Filaments* , 2000, The Journal of Biological Chemistry.
[41] R Nussinov,et al. Point mutations and sequence variability in proteins: Redistributions of preexisting populations , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[42] C. Haass,et al. Physiology and Pathophysiology of α‐Synuclein: Cell Culture and Transgenic Animal Models Based on a Parkinson's Disease‐associated Protein , 2000, Annals of the New York Academy of Sciences.
[43] S. Lindquist,et al. Yeast Cells Provide Insight into Alpha-Synuclein Biology and Pathobiology , 2003, Science.
[44] Martina Huber,et al. Direct evidence of coexisting horseshoe and extended helix conformations of membrane-bound alpha-synuclein. , 2011, Chemphyschem : a European journal of chemical physics and physical chemistry.
[45] R. Ranganathan,et al. Evolutionarily conserved pathways of energetic connectivity in protein families. , 1999, Science.
[46] C. Griesinger,et al. Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[47] B. Vallee,et al. Tetranitromethane. A reagent for the nitration of tyrosyl residues in proteins. , 1966, Biochemistry.
[48] Luca Pinato,et al. A Topological Model of the Interaction between α-Synuclein and Sodium Dodecyl Sulfate Micelles† , 2005 .
[49] Janel O. Johnson,et al. α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.
[50] B. Giasson,et al. Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. , 2000, The Journal of biological chemistry.
[51] M. Goedert,et al. Cysteine misincorporation in bacterially expressed human α‐synuclein , 2006 .
[52] C. Griesinger,et al. Familial Mutants of α-Synuclein with Increased Neurotoxicity Have a Destabilized Conformation* , 2005, Journal of Biological Chemistry.
[53] E. Daikhin,et al. Proteolytic degradation of tyrosine nitrated proteins. , 2000, Archives of biochemistry and biophysics.
[54] C. Dobson,et al. Differential Phospholipid Binding of α-Synuclein Variants Implicated in Parkinson’s Disease Revealed by Solution NMR Spectroscopy† , 2009, Biochemistry.
[55] T. Südhof,et al. α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro , 2010, Science.
[56] C. Dobson,et al. Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations. , 2005, Journal of the American Chemical Society.
[57] C. Griesinger,et al. Interaction of alpha-synuclein with divalent metal ions reveals key differences: a link between structure, binding specificity and fibrillation enhancement. , 2006, Journal of the American Chemical Society.
[58] D. Eliezer,et al. Conformational properties of alpha-synuclein in its free and lipid-associated states. , 2001, Journal of molecular biology.
[59] M. Ebadi,et al. Reactive Macrophages Increase Oxidative Stress and Alpha-Synuclein Nitration During Death of Dopaminergic Neuronal Cells in Co-Culture: Relevance to Parkinson’s Disease , 2005, Neurochemical Research.
[60] Reinhard Jahn,et al. A Broken α-Helix in Folded α-Synuclein* , 2003, The Journal of Biological Chemistry.
[61] Birgit Schilling,et al. Preferentially increased nitration of alpha-synuclein at tyrosine-39 in a cellular oxidative model of Parkinson's disease. , 2009, Analytical chemistry.
[62] M. Blackledge,et al. Defining long-range order and local disorder in native alpha-synuclein using residual dipolar couplings. , 2005, Journal of the American Chemical Society.